Medincell's partner teva announces successful launch of uzedy™

Montpellier, france--(business wire)--medincell (paris:medcl): access here the complete press release during today's q2 earnings call, richard francis, president and ceo of teva, and eric hughes, executive vice president, global r&d & chief medical officer, commented the us launch of uzedy since may 2023 and the olanzapine long-acting injectable (lai). about uzedy richard francis said1: “we are actually right on plan or slightly ahead of our market access strategy targets and we are ver.
TEVA Ratings Summary
TEVA Quant Ranking